Oral ENA713 (0.5, 1.5 and 4.5 mg/kg), an acetylcholinesterase inhibitor (AChEI), dose-dependently enhanced extracellular acetylcholine concentrations in the hippocampus of freely moving rats. This effect was paralleled by changes in both noradrenergic and dopaminergic transmission. In particular, ENA713 significantly decreased noradrenaline concentrations, whereas it significantly increased homovanillic acid levels, without affecting dopamine concentrations. Neither serotonin nor gamma-aminobutyric acid levels were modified by ENA713. These findings extend the neurochemical profile of ENA713 and suggest that it could be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.

In vivo neurochemical effects of the acethylcholinesterase inhibitor ENA713 in rat hippocampus / Trabace, L; Coluccia, A; Gaetani, Silvana; Tattoli, M; Cagiano, R; Pietra, C; Kendrick, Km; Cuomo, Vincenzo. - In: BRAIN RESEARCH. - ISSN 0006-8993. - STAMPA. - 865(2):(2000), pp. 268-271. [10.1016/S0006-8993(00)02266-6]

In vivo neurochemical effects of the acethylcholinesterase inhibitor ENA713 in rat hippocampus

GAETANI, SILVANA;CUOMO, VINCENZO
2000

Abstract

Oral ENA713 (0.5, 1.5 and 4.5 mg/kg), an acetylcholinesterase inhibitor (AChEI), dose-dependently enhanced extracellular acetylcholine concentrations in the hippocampus of freely moving rats. This effect was paralleled by changes in both noradrenergic and dopaminergic transmission. In particular, ENA713 significantly decreased noradrenaline concentrations, whereas it significantly increased homovanillic acid levels, without affecting dopamine concentrations. Neither serotonin nor gamma-aminobutyric acid levels were modified by ENA713. These findings extend the neurochemical profile of ENA713 and suggest that it could be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.
2000
acetylcholinesterase inhibitor ENA713; neurotransmitters; rat hippocampus; Alzheimer's disease
01 Pubblicazione su rivista::01a Articolo in rivista
In vivo neurochemical effects of the acethylcholinesterase inhibitor ENA713 in rat hippocampus / Trabace, L; Coluccia, A; Gaetani, Silvana; Tattoli, M; Cagiano, R; Pietra, C; Kendrick, Km; Cuomo, Vincenzo. - In: BRAIN RESEARCH. - ISSN 0006-8993. - STAMPA. - 865(2):(2000), pp. 268-271. [10.1016/S0006-8993(00)02266-6]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/255808
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 17
social impact